Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology Learning Network
Posttreatment dosimetric analysis demonstrated that higher specific activity microspheres overcome tumor heterogeneity by ensuring adequate radiation delivery throughout the entire tumor volume, particularly in poorly perfused regions.
Hepatology June 24th 2025
UCLA Health
The procedure addresses limitations of current intestinal reconstruction methods, potentially eliminating associated bleeding risks, infections, and digestive complications while providing more physiologically normal urinary function.
Nephrology May 27th 2025
Oncology News Central (ONC)
The phase 3 ALLELE trial demonstrated tabelecleucel’s potential with a 50.7% overall response rate and median duration of response of 23.0 months in EBV+ PTLD patients.
Hematology/Oncology February 3rd 2025
Cleveland Clinic Journal of Medicine (CCJM)
In lung transplant recipients presenting with acute respiratory symptoms, a broad differential diagnosis and prompt, comprehensive evaluation are crucial. This case highlights the significance of considering opportunistic infections and the necessity of early empiric antimicrobial therapy to prevent rapid deterioration.
Cardiology June 7th 2024
Cardiac complications significantly influence the success of liver transplants. Effective preoperative cardiac risk stratification and careful intraoperative management are essential to optimize patient outcomes.
Cardiology May 16th 2024
Primary care physicians are crucial in managing the intricate health complications of allogeneic HCT survivors, including chronic graft-vs-host disease and increased cardiovascular risks.
Family Medicine/General Practice May 13th 2024